◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Blue Jet Healthcare Limited (BLUEJET) Financial History

Name: Blue Jet Healthcare Limited (BLUEJET) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-09-20

Blue Jet Healthcare Limited (BLUEJET) operates in the Biotechnology industry and is headquartered in Thane, India with about 581 employees. Its market capitalization is roughly ₹100 billion. In the fiscal year ended 2026-03-31, BLUEJET reported ₹9.4B in revenue and ₹2.5B in net income.

Blue Jet Healthcare Limited engages in the manufacturing and sale of artificial sweeteners, pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in products.

Interactive charts & full statements →

BLUEJET Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹9.4B	₹10.3B	₹7.1B	₹7.2B	—
Gross Profit	₹5.0B	₹5.6B	₹3.9B	₹3.8B	—
Operating Income (EBIT)	₹2.7B	₹3.6B	₹2.0B	₹1.9B	—
Net Income	₹2.5B	₹3.1B	₹1.6B	₹1.6B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLUEJET Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹2.9B	₹2.3B	₹1.9B	₹3.5B	₹3.4B	—
Gross Profit	₹1.6B	₹1.3B	₹996M	₹1.7B	₹1.9B	—
Operating Income (EBIT)	₹914M	₹648M	₹409M	₹1.2B	₹1.4B	—
Net Income	₹783M	₹643M	₹402M	₹912M	₹1.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLUEJET Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹208M)	(₹174M)	₹0M	₹0M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLUEJET Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹16.4B	₹14.2B	₹10.6B	₹8.6B	—
Total Liabilities	₹2.8B	₹2.8B	₹2.1B	₹1.8B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BLUEJET viewer.

Other Companies in Biotechnology

4587 · PeptiDream Inc. — JPY 138 billion
VRTX · Vertex Pharmaceuticals — $129 billion
4565 · Nxera Pharma Co., Ltd. — JPY 119 billion
6990 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. — HK$110 billion
1177 · Sino Biopharmaceutical Limited — HK$97 billion
1548 · Genscript Biotech Corporation — HK$90 billion
9926 · Akeso, Inc. — HK$83 billion
REGN · Regeneron Pharmaceuticals — $81 billion

← BLUEDART All “B” companies BLUESTARCO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.